BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2016 1:33:00 PM | Browse: 1143 | Download: 2480
 |
Received |
|
2016-07-01 09:38 |
 |
Peer-Review Started |
|
2016-07-01 16:05 |
 |
To Make the First Decision |
|
2016-07-29 18:53 |
 |
Return for Revision |
|
2016-08-03 14:01 |
 |
Revised |
|
2016-08-14 21:26 |
 |
Second Decision |
|
2016-09-21 15:50 |
 |
Accepted by Journal Editor-in-Chief |
|
2016-09-21 17:43 |
 |
Accepted by Executive Editor-in-Chief |
|
2016-09-28 17:57 |
 |
Articles in Press |
|
2016-09-28 17:58 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-11-09 15:22 |
 |
Publish the Manuscript Online |
|
2016-11-12 13:34 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Retrospective Study |
Article Title |
Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jean-Florian Guion-Dusserre, Aurélie Bertaut, François Ghiringhelli, Julie Vincent, Valérie Quipourt, Sophie Marilier, Zoé Tharin and Leila Bengrine-Lefevre |
Funding Agency and Grant Number |
|
Corresponding Author |
Francois Ghiringhelli, MD, PhD, Department of Medical Oncology, Centre Georges François Leclerc, INSERM Avenir 866, 1, rue du Professeur Marion, 21000 Dijon, France. fghiringhelli@cgfl.fr |
Key Words |
Elderly patients; Feasibility treatment; Pancreatic cancer; Colorectal cancer; FOLFIRINOX |
Core Tip |
The incidence of cancer in patients over 70 years old is still increasing, especially for pancreatic and colorectal cancer. Database is missing concerning elderly patients, especially for considered aggressive chemotherapies, like FOLFIRINOX. The aim of this retrospective study was to show the feasibility of a combination chemotherapies (FOLFIRINOX) in an elderly population, by initially adapting the treatment dose, according to the patient’s general condition and comorbidities. We surprisingly observed prolonged survival and manageable toxicity levels. |
Publish Date |
2016-11-12 13:34 |
Citation |
Guion-Dusserre JF, Bertaut A, Ghiringhelli F, Vincent J, Quipourt V, Marilier S, Tharin Z, Bengrine-Lefevre L. Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy. World J Gastroenterol 2016; 22(42): 9378-9386 |
URL |
http://www.wjgnet.com/1007-9327/full/v22/i42/9378.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v22.i42.9378 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345